Skip to main
We’re doing some system maintenance
  1. /
  2. Stocks
  3. /
  4. China Biologic Products Holdings
CBPO

Buy CBPO Stock

CBPO
See CBPO stock price and Buy/Sell China Biologic Products Holdings with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
CBPO

China Biologic Products Holdings (CBPO)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About China Biologic Products Holdings (CBPO)

Taibang Biologic Group is a Chinese biopharmaceutical company that provides a comprehensive range of plasma-derived products. The company's core business includes the development, manufacture, and sale of plasma-derived products and other biopharmaceutical products.
Market Cap
$4.66B
1 Year High
$120.05
Volume
1 Year Low
$99.74
Price to Earnings Ratio
30.40
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch CBPO stock

CBPO Stock Rating

What analysts recommend for CBPO stock, on a scale from 1(buy) to 5(sell).
Hold3 / 5
BuyHoldSell

CBPO Stock Earnings

The value each CBPO share was expected to gain vs. the value that each CBPO share actually gained.
Expected
Actual

CBPO Stock News

Frequently Asked Questions (FAQ)

As of Sep 28, 2022, the market cap for CBPO stock is $4.66B

The current P/E ratio for CBPO stock is 30.4

The 52-week high for CBPO stock is $120.05. The current CBPO stock price $0 is 100.00% below its 52-week high

The 52-week low for CBPO stock is $99.74. The current CBPO stock price $0 has increased 100.00% from its 52-week low

No, the CBPO stock does not pay dividends to its shareholders

The target price for CBPO stock is $119 based on the average of what a group of analyst think CBPO stock could be worth at a future date. This is not a prediction by Public.com

Buy CBPO Stock

CBPO
See CBPO stock price and Buy/Sell China Biologic Products Holdings with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch CBPO stock
  • shawnski avatar
  • kalapono28 avatar
  • dandiwer avatar
  • MartinMoney avatar
  • Dash96 avatar
Products
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Our clearing firm, Apex Clearing Corporation, has purchased an additional insurance policy. The coverage limits provide protection for securities and cash up to an aggregate of $150 million, subject to maximum limits of $37.5 million for any one customer’s securities and $900,000 for any one customer’s cash. Similar to SIPC protection, this additional insurance does not protect against a loss in the market value of securities.

Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are over-the-counter equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). Dalmore and Open to the Public Investing are not affiliated entities. This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. The issuers of these securities may be an affiliate of Public, and Public (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures, Apex Crypto.

Dalmore and Apex Crypto, LLC are not affiliated with any of the Public Holdings subsidiaries.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S.-listed, registered securities electronically. Keep in mind that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more. All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.